Citizens Jmp Reaffirms “Market Outperform” Rating for Option Care Health (NASDAQ:OPCH)

Option Care Health (NASDAQ:OPCH)‘s stock had its “market outperform” rating restated by analysts at Citizens Jmp in a research note issued on Tuesday,Benzinga reports. They currently have a $38.00 target price on the stock, up from their previous target price of $36.00. Citizens Jmp’s price objective would indicate a potential upside of 9.03% from the stock’s current price.

Several other research analysts have also commented on OPCH. Barrington Research reiterated an “outperform” rating and issued a $38.00 price target on shares of Option Care Health in a research report on Friday, October 31st. JMP Securities set a $36.00 target price on shares of Option Care Health in a research report on Friday, October 31st. Citigroup reissued an “outperform” rating on shares of Option Care Health in a research report on Tuesday. Bank of America lifted their price target on shares of Option Care Health from $32.00 to $35.00 and gave the stock a “buy” rating in a report on Tuesday, December 9th. Finally, Weiss Ratings reaffirmed a “hold (c)” rating on shares of Option Care Health in a research report on Monday, December 29th. One investment analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and three have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $36.45.

Option Care Health Price Performance

OPCH traded up $2.79 during trading on Tuesday, hitting $34.85. 529,426 shares of the company traded hands, compared to its average volume of 1,792,630. The company has a current ratio of 1.56, a quick ratio of 1.05 and a debt-to-equity ratio of 0.85. The company has a market cap of $5.53 billion, a PE ratio of 27.65, a P/E/G ratio of 1.98 and a beta of 0.80. The stock’s 50-day simple moving average is $30.83 and its two-hundred day simple moving average is $29.40. Option Care Health has a 1 year low of $24.24 and a 1 year high of $35.53.

Insider Buying and Selling

In other Option Care Health news, Director Harry M. Jansen Kraemer, Jr. bought 38,000 shares of the firm’s stock in a transaction dated Monday, November 3rd. The shares were purchased at an average price of $25.98 per share, for a total transaction of $987,240.00. Following the transaction, the director directly owned 413,390 shares of the company’s stock, valued at approximately $10,739,872.20. This represents a 10.12% increase in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Insiders own 0.64% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds have recently modified their holdings of the stock. Strs Ohio acquired a new stake in Option Care Health in the 1st quarter worth about $636,000. Boston Partners lifted its position in shares of Option Care Health by 34.8% in the second quarter. Boston Partners now owns 952,299 shares of the company’s stock valued at $30,311,000 after acquiring an additional 245,990 shares in the last quarter. Swedbank AB purchased a new position in shares of Option Care Health in the third quarter valued at approximately $49,455,000. Fort Washington Investment Advisors Inc. OH boosted its stake in shares of Option Care Health by 11.8% in the second quarter. Fort Washington Investment Advisors Inc. OH now owns 883,404 shares of the company’s stock worth $28,693,000 after acquiring an additional 92,984 shares during the last quarter. Finally, Aristides Capital LLC purchased a new stake in shares of Option Care Health during the second quarter worth approximately $249,000. Institutional investors and hedge funds own 98.05% of the company’s stock.

Option Care Health Company Profile

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.